Mohammed MA, Syeda JTM, Wasan KM, Wasan EK
To study how benefits are distributed, we stratify people by age at treatment initiation and by risk assessed one of two ways: BMI at time of treatment initiation
Developing scalable and cost-effective manufacturing techniques is essential to make liposome-based dermatological products accessible to a wider population
Patients using semaglutides, or glucagon-like peptide-1 (GLP-1) agonists, who lost versus gained weight demonstrated distinct patterns of changes in CT-based body composition measures, wrote corresponding author and former ARRS Scholar Perry Pickhardt, MD, from the radiology department at the University of Wisconsin School of Medicine & Public Health in Madison
For daily injections, rotate between at least three sites to prevent injection site reactions and lipohypertrophy